MedPage Today | 10 Questions: Robert Spiera, MD MedPage Today In the ensuing nearly 2 decades, many other such biologics have been developed for the treatment of rheumatoid arthritis, lupus, and with the demonstration of the efficacy of rituximab in ANCA-associated vasculitis, the promise of our science leading ... |
